Assenagon Asset Management S.A. Arvinas, Inc. Transaction History
Assenagon Asset Management S.A.
- $60.5 Billion
- Q2 2025
A detailed history of Assenagon Asset Management S.A. transactions in Arvinas, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 50,366 shares of ARVN stock, worth $378,752. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,366
Previous 82,879
39.23%
Holding current value
$378,752
Previous $581,000
36.32%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARVN
# of Institutions
249Shares Held
62.5MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$62.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$47.1 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$29.1 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$28.8 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$25.1 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $400M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...